Vermögenswerte Veränderung Datum
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 96.05B 409M 2026-09
Arrowhead Research USD 1.74B 373.76M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Moderna USD 13.47B 2.51B 2026-09
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Tectonic Therapeutic USD 237.03M 9.54M 2026-06
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09